3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Neutropenia
1
Neoplasms
1
Hematologic Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
pegfilgrastim
3
Vancomycin
2
Teicoplanin
2
Meropenem
2
Filgrastim
2
Ciprofloxacin
2
Ceftazidime
2
Cefepime
2
posaconazole
1
pegylated granulocyte colony-stimulating factor
1
Vascular Access Devices
1
Ofloxacin
1
Metronidazole
1
Leucovorin
1
Lenograstim
1
Irinotecan
1
Fluorouracil
1
Cilastatin, Imipenem Drug Combination
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Neutropenia
×
Cilastatin, Imipenem Drug Combination
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled